Iran's New Leader Breaks Silence, Issues Threats Against US and Arab Neighbors
Gavin Newsom Is Crushing the Field in This 2028 Preview
We Can See Why This NYT Reporter Deleted His Post About the NYC...
The Old Dominion University Shooter Has Been ID'd and It Looks Like Islamic...
After Threatening ICE Agents, a Wisconsin Man Enters the FO Stage
Democrats Are Attacking Hegseth's Supposed Steak Budget. They'll Hate This Next Number.
UPDATE: Suspected MI Synagogue Shooter Engaged by Security, Reportedly Dead
Check Out What London Is Now Recommending City Buses Carry for Some Unspoken...
Gunman Dead After Opening Fire at Old Dominion University in Norfolk, Virginia
Victor Davis Hanson Reveals Three Ways Operation Epic Fury Ends, And Why They...
Fetterman Goes Off on Fellow Democrats: Why Can’t They Just Admit Operation Epic...
The White House Pushes Back on Reports That Iran Could Be Targeting the...
President Trump Unloads on Thomas Massie at Kentucky Rally: ‘We Gotta Get Rid...
Tim Burchett Blasts ‘Snobs’ Attacking Trump DHS Nominee Markwayne Mullin Over Lack of...
Trans Mania Sweeps New Mexico Schools – Even Elementaries Will ‘Affirm’ Gender Choices
Tipsheet

Operation Warp Speed Chief Says Things Will Get Back to Normal Once This Happens

Operation Warp Speed Chief Says Things Will Get Back to Normal Once This Happens
AP Photo/Paul Sancya

The chief adviser of Operation Warp Speed, Moncef Slaoui, said on Sunday that he sees light at the end of the tunnel when it comes to the coronavirus pandemic, predicting a return to normal once a coronavirus vaccine becomes widely available. As for when the top adviser expects that to happen, Slauoui said sometime around April or May. 

Advertisement

"I think we may start to see some impact on the most susceptible people probably in the month of January and February, but on a population basis, for our lives to start getting back to normal, we're talking about April or May," Slaoui told CBS' "Face the Nation" on Sunday. 

Food and Drug Administration (FDA) officials are set to meet on Thursday to vote on whether or not to grant emergency use authorization of Pfizer's vaccine candidate.

Slaoui encouraged Americans to "take comfort in the fact that we have light at the end of the tunnel and find the energy in that to continue to wear our masks, distance, wash our hands, pay attention to what we are doing to make sure that we are there by the spring to benefit from the vaccine."

The top adviser said he expects the FDA to make a positive decision, but said "of course, it's their decision." 

"And as you probably know, they are totally separated and firewalled from the operation," Slaoui said. "They will make their own judgment based on the data. And I hope that the decision will be positive."

Slaoui said shipments will go out to the states as soon as a vaccine is approved by the FDA. 

Advertisement

Pfizer's drug has shown to be 95 percent effective in preventing COVID-19 infections. The FDA is also set to consider Moderna's request for an emergency use authorization next week. Moderna's vaccine candidate has shown to be over 94 percent effective in clinical trials.

According to the Centers for Disease Control and Prevention, healthcare workers and residents of long-term care facilities should be first in line for vaccination. Individuals over the age of 65, essential workers, and those with underlying medical conditions should be vaccinated in a second phase.

The Trump administration's Operation Warp Speed helped expedite the development of vaccine candidates for the Wuhan coronavirus. The Trump administration has also been working with states and local governments to rush the distribution of a vaccine once a candidate receives authorization from the FDA. 

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos